Key result
The DoubleCheck-AF wearable device, combining continuous photoplethysmography and on-demand 6-lead ECG, detected atrial fibrillation with 94.2% sensitivity and 99.6% specificity, maintaining high accuracy even in patients with frequent premature contractions.
Why the study?
Consumer smartwatches for AF detection face limitations because PPG has movement artifacts and ECG cannot be used continuously, usually provides only a single-lead signal, and is limited in asymptomatic cases.
Does a wrist-worn device combining continuous PPG and a 6-lead ECG accurately detect atrial fibrillation and differentiate it from sinus rhythm with frequent premature contractions compared to a Holter monitor?
Case-Control (n=344)
Blinded assessors
No
Does a wrist-worn device combining continuous PPG and a 6-lead ECG accurately detect atrial fibrillation and differentiate it from sinus rhythm with frequent premature contractions compared to a Holter monitor?
A novel wrist-worn device combining PPG and a 6-lead ECG demonstrated high sensitivity and specificity for detecting atrial fibrillation, effectively mitigating false positives caused by frequent premature contractions.
Answers are grounded in this paper and cite their sources.
Supports wearable AF detection amid ectopy; hypothesis-generating and requires randomized validation before clinical adoption.
Background Consumer smartwatches have gained attention as mobile health (mHealth) tools able to detect atrial fibrillation (AF) using photoplethysmography (PPG) or a short strip of electrocardiogram (ECG). PPG has limited accuracy due to the movement artifacts, whereas ECG cannot be used continuously, is usually displayed as a single-lead signal and is limited in asymptomatic cases. Objective DoubleCheck-AF is a validation study of a wrist-worn device dedicated to providing both continuous PPG-based rhythm monitoring and instant 6-lead ECG with no wires. We evaluated its ability to differentiate between AF and sinus rhythm (SR) with particular emphasis on the challenge of frequent premature beats. Methods and Results We performed a prospective, non-randomized study of 344 participants including 121 patients in AF. To challenge the specificity of the device two control groups were selected: 95 patients in stable SR and 128 patients in SR with frequent premature ventricular or atrial contractions (PVCs/PACs). All ECG tracings were labeled by two independent diagnosis-blinded cardiologists as “AF,” “SR” or “Cannot be concluded.” In case of disagreement, a third cardiologist was consulted. A simultaneously recorded ECG of Holter monitor served as a reference. It revealed a high burden of ectopy in the corresponding control group: 6.2 PVCs/PACs per minute, bigeminy/trigeminy episodes in 24.2% (31/128) and runs of ≥3 beats in 9.4% (12/128) of patients. AF detection with PPG-based algorithm, ECG of the wearable and combination of both yielded sensitivity and specificity of 94.2 and 96.9%; 99.2 and 99.1%; 94.2 and 99.6%, respectively. All seven false-positive PPG-based cases were from the frequent PVCs/PACs group compared to none from the stable SR group ( P < 0.001). In the majority of these cases (6/7) cardiologists were able to correct the diagnosis to SR with the help of the ECG of the device ( P = 0.012). Conclusions This is the first wearable combining PPG-based AF detection algorithm for screening of AF together with an instant 6-lead ECG with no wires for manual rhythm confirmation. The system maintained high specificity despite a remarkable amount of frequent single or multiple premature contractions.
No takes yet. Share an insight, caveat, or question.
Bacevičius et al. (2022) conducted a case-control in Atrial fibrillation (n=344). DoubleCheck-AF wearable device vs. Holter monitor was evaluated on Atrial fibrillation detection accuracy (sensitivity and specificity) of the combined PPG and 6-lead ECG system vs all SR groups (Sensitivity 94.2%, Specificity 99.6%). The DoubleCheck-AF wearable device, combining continuous photoplethysmography and on-demand 6-lead ECG, detected atrial fibrillation with 94.2% sensitivity and 99.6% specificity, maintaining high accuracy even in patients with frequent premature contractions.
Synapse has enriched 10 related papers. Consider them for comparative context: